Latest National Institute for Health and Clinical Excellence Stories
By JEREMY LAURANCE The big question Why are we asking this now? CANCER CHARITIES, kidney specialists and campaigners were outraged yesterday when the National Institute for Clinical Excellence (Nice), announced that it had rejected four new drugs for advanced kidney cancer as too expensive for the NHS.
PATIENTS with advanced kidney cancer will be denied four treatments on the NHS under new guidelines. The National Institute for Health and Clinical Excellence (Nice) issued draft guidance rejecting the drugs. Charities expressed outrage at the decision. (c) 2008 Liverpool Echo.
By JANE KIRBY PATIENTS with advanced kidney cancer will be denied four treatments on the NHS under new guidelines published yesterday.
By Greg Tindle A WELSH cancer expert has described as "an outrage" plans to deny patients with advanced kidney cancer four types of drug treatment on the NHS.
By Emma Brady Midland cancer experts have hit out at a decision to deny kidney cancer patients four drugs under new NHS guidelines issued yesterday.
By HELEN RAE PATIENTS with advanced kidney cancer will be denied four life- extending treatments on the NHS because they are not cost effective.
By HELEN PUTTICK HEALTH CORRESPONDENT CHARITIES yesterday spoke out about the NHS refusing patients new treatments for a rare form of cancer.
PATIENTS with advanced kidney cancer will be denied four treatments on the NHS under new guidelines published today.
By JANE KIRBY Broadcaster James Whale accused a health watchdog today of being "barbaric" in denying kidney cancer patients access to four drugs.
GlaxoSmithKline plans to renegotiate with the UK's Department of Health as part of its attempt to reverse the National Health Service's decision regarding the company's cancer drug Tyverb, reported the Financial Times.
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.